Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06072339Terminated
Randomised, open-label trial (2 arms), sponsored by CHU Montpellier. Primary endpoint: Arterial oxygen pressure / inspired oxygen fraction ratio at 30 minutes. Started Dec 2023; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06072339.